Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Outlook Therapeutics | 41O | Sep 20, 2024 | 5.30 | -0.93 |
Outokumpu | OUTA | Sep 20, 2024 | 3.34 | +2.14 |
OUTSURANCE GROUP LTD. | RMQ0 | Sep 20, 2024 | 2.78 | 0.00 |
Ovation Science Inc Common Shares (Canada) | 0VH | Sep 20, 2024 | 0.00 | -18.18 |
Ovb Holding | O4B | Sep 20, 2024 | 18.90 | +1.07 |
Oversea-chinese Banking Corp | OCBB | Sep 20, 2024 | 21.20 | 0.00 |
Oversea-Chinese Banking Corporation Limited | OCBA | Sep 20, 2024 | 10.64 | -1.53 |
Overstock.com, Inc. | OVER | Sep 20, 2024 | 9.20 | -4.86 |
OVH Groupe | 7U7 | Sep 20, 2024 | 6.21 | +3.76 |
OVH GROUPE UNSP.ADR/1/2 | 7U70 | Sep 20, 2024 | 2.60 | -3.70 |
Ovid Therapeutics Inc. | 1OT | Sep 20, 2024 | 1.01 | +9.78 |
Ovintiv Inc. (DE) | 47Q | Sep 20, 2024 | 35.84 | -0.64 |
Ovs SPA | 0OV1 | Sep 20, 2024 | 2.78 | -0.50 |
Ovzon | OVZ | Sep 20, 2024 | 1.33 | -2.64 |
Owens & Minor, Inc. | 6OM | Sep 20, 2024 | 14.10 | -0.70 |
Owens Corning Inc | O5Q | Sep 20, 2024 | 155.70 | +0.94 |
Owl Rock Capital Corporation | 1D6 | Sep 20, 2024 | 13.37 | -0.31 |
OX2 AB | 4DA | Sep 20, 2024 | 5.27 | +0.38 |
OXE Marine | 5LK | Sep 20, 2024 | 0.01 | +95.45 |
Oxford BioDynamics plc | LMQ | Sep 20, 2024 | 0.06 | +171.74 |
Oxford Biomedica | OXOA | Sep 20, 2024 | 4.12 | +3.00 |
Oxford Industries, Inc. | OXD | Sep 20, 2024 | 77.00 | -0.65 |
Oxford Instruments PLC | OX3 | Sep 20, 2024 | 24.20 | +1.68 |
Oxford Lane Capital Corp. | 4RQ | Sep 20, 2024 | 4.63 | -0.76 |
Oxford Lane Capital Corp. - 6.25% Series 2027 Term Preferred | 4RQ0 | Sep 20, 2024 | 21.00 | 0.00 |
Oxford Metrics plc | RNI | Sep 20, 2024 | 0.90 | -2.17 |
Oxford Square Capital Corp. - Closed End Fund | 22T | Sep 20, 2024 | 2.50 | -1.38 |
Oxley Holdings Limited | 8OX1 | Sep 20, 2024 | 0.05 | +3.37 |
Oxurion NV | TG40 | Sep 20, 2024 | 0.50 | 0.00 |
P10 Inc | AC3 | Sep 20, 2024 | 9.50 | +1.60 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.